NIH 'not done' fighting Moderna over Covid vaccine patents, director Francis Collins says
The NIH is standing by its assertion that three of its scientists should be listed in the Moderna patent for the company’s lucrative Covid-19 vaccine.
The spat is part of an ongoing feud between the US government and Moderna that spilled into public view last month when one of President Joe Biden’s top medical advisors called out the company for failing to deliver on its promise to vaccinate more low- and middle-income countries.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.